APSR2026-694

Yes
Late-Breaking
Submitted
Oral Presentation
AO01-005
 
 
https://storage.unitedwebnetwork.com/files/1285/1216194-46903-APSR2026-694_429367.pptx
Format: PPTX Only
 
Format: PDF Only
09. Asthma
8

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

King-Pui Florence Chan * Queen Mary Hospital, The University of Hong Kong Department of Medicine Hong Kong Hong Kong
Ki Lam - Queen Mary Hospital, The University of Hong Kong Department of Pathology Hong Kong Hungary
Yuey Zhun Michael Ng - Queen Mary Hospital, The University of Hong Kong Department of Microbiology Hong Kong Hong Kong
Yuen Ling Elaine Aug - Queen Mary Hospital, The University of Hong Kong Department of Pathology Hong Kong Hong Kong
Siu Leung Fung - Grantham Hospital Tubeculosis and Chest Unit Hong Kong Hong Kong
James Chung Man Ho - Queen Mary Hospital, The University of Hong Kong Department of Medicine Hong Kong Hong Kong
Kwok Yung Yuen - Queen Mary Hospital, The University of Hong Kong Department of Microbiology Hong Kong Hong Kong
Ivan Fan-Ngai Hung - Queen Mary Hospital, The University of Hong Kong Department of Medicine Hong Kong Hong Kong
 
 
 
 
 
 
 
Presenting Author Details
King-Pui Florence
Chan
kpfchan@hku.hk
+85294448780
31-40
 
Original Research
Staphylococcus aureus nasal carriage in asthma patients and severe exacerbation risk – A territory-wide study
Maximum 25 words
Abstract Content
Staphylococcus aureus nasal carriage triggers the release of serum IgE against S. aureus enterotoxin (SEIgE). It is an independent risk in developing asthma and is associated with severe asthma. There is limited epidemiological data from Asian countries on nasal carriage of S. aureus in patients with asthma and on clinical outcomes. This study aims to address this knowledge gap.
Territory-wide retrospective study on adult asthma patients presented between 2015 and 2019. The patients were followed up for 5 years for any asthma exacerbation requiring hospitalisation. Baseline demographics, drug usage and hospital admission details, including severity with intensive care unit (ICU) admission and intubation, were recorded.
Between 1 Jan 2015 and 31 Dec 2019, a total of 44,832 adult patients had a record of asthma diagnosis, with 26,359 (58%) female, mean age 59.3 ± 19.8. The eosinophil counts were available in 39,875 patients, with a median of 0.19 ± 0.45. Among the 44,832 patients, 1,172 (2.6%) were screened positive with S. aureus, with 1,068 (2.4%) with Methicillin-resistant Staphylococcus aureus (MRSA), 121 (0.3%) with Methicillin-sensitive Staphylococcus aureus (MSSA) and 17 (0.04%) with both MRSA and MSSA. 13,394 (29.9%) had exacerbations that required hospitalisation with a median length of stay of 3.14+/-13.6 days, of which 1,200 (9.0%) required intensive care unit admission and 229 (0.9%) required intubation. Risk factors for hospitalisation included S. aureus carriage (OR 4.36, 95%CI 3.86-4.92) and triple inhaler therapy upon diagnosis (OR 5.40, 95%CI 5.04-5.80). S. aureus carriage (OR 3.44, 95%CI 2.91-4.07) and triple inhaler therapy (OR 2.32, 95%CI 2.07-2.59) were more commonly seen in asthma exacerbation requiring ICU admission (Table 1).
S. aureus carriage in asthma patients showed a higher risk of asthma exacerbation requiring hospitalisation and more ICU admissions in this territory-wide database. Further prospective study is needed to ascertain the carriage rate and the role of nasal carriage of S. aureus to guide future management.
 
 
 
 
 
No
Yes
https://storage.unitedwebnetwork.com/files/1285/1216194-37089-table1_381208.jpg
JPG or JPEG or PNG format ONLY
Asthma, Staphylococcus aureus, SEIgE
maximum 3 keywords and no abbreviations, separated by commas
 
345